Fwd: [EXTERN] Final Decision made for NPHOT-2024-04-00624B
I think the acceptance of the paper deserves a lab bar! When are you all available? Drinks on me :) Best, Pierre Pierre Bouvet, PhD Post-doctoral Fellow Medical University Vienna Department of Anatomy and Cell Biology Wahringer Straße 13, 1090 Wien, Austria
Begin forwarded message:
From: giampaolo.pitruzzello@nature.com Subject: [EXTERN] Final Decision made for NPHOT-2024-04-00624B Date: 16. April 2025 at 00:52:09 GMT+2 To: pierre.bouvet@meduniwien.ac.at Reply-To: giampaolo.pitruzzello@nature.com
Dear Dr Bouvet,
Please find below a copy of the decision letter for your manuscript "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials" [NPHOT-2024-04-00624B], which has just been accepted for publication in Nature Photonics.
You can now use a single sign-on for all your accounts, view the status of all your manuscript submissions and reviews, access usage statistics for your published articles and download a record of your refereeing activity for the Nature journals.
To assist our authors in disseminating their research to the broader community, our SharedIt initiative provides all co-authors with the ability to generate a unique shareable link that will allow anyone (with or without a subscription) to read the published article. Recipients of the link with a subscription will also be able to download and print the PDF.
As soon as your article is published, you can generate your shareable link by entering the DOI of your article here: <http://authors.springernature.com/share>http://authors.springernature.com/share. Corresponding authors will also receive an automated email with the shareable link.
Sincerely,
Dr Giampaolo Pitruzzello Senior Editor Nature Photonics
------------------------------------------------------------------------ Subject: Acceptance note for Nature Photonics manuscript NPHOT-2024-04-00624B
15th April 2025
Dear Kareem,
All your hard work has paid off and I am delighted to inform you that your manuscript, "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials", has now been formally accepted for publication in Nature Photonics. Congratulations! It's been a long journey and I am so glad to see this piece now finalised. I do think it will be a valuable resource for the Brillouin community.
Before your manuscript is typeset, we will edit the text to ensure that your findings are clear to our wide readership and that the paper conforms with Nature Photonics style. We look particularly carefully at the titles of all papers to ensure that they are concise and clear.
Once your manuscript is typeset and you have completed the appropriate grant of rights, you will receive a link to your electronic proof via email with a request to make any corrections within 48 hours. If, when you receive your proof, you cannot meet this deadline, please inform us at rjsproduction@springernature.com immediately.
You may wish to make your media relations office aware of your accepted publication, in case they consider it appropriate to organize some internal or external publicity. Once your paper has been scheduled you will receive an email confirming the publication details. This is normally 3-4 working days in advance of publication. If you need additional notice of the date and time of publication, please let the production team know when you receive the proof of your article to ensure there is sufficient time to coordinate. Further information on our embargo policies can be found here: <>https://www.nature.com/authors/policies/embargo.html
Acceptance of your manuscript is conditional upon all authors' agreement with our publication policies (see http://www.nature.com/nphoton/authors/index.html#publishing-policies). In particular, your manuscript must not be published elsewhere and there must be no announcement of the work to any media outlet until the publication date (the day on which it is uploaded onto our website).
Authors may need to take specific actions to achieve compliance <https://www.springernature.com/gp/open-research/funding/policy-compliance-fa...> with funder and institutional open access mandates. If your research is supported by a funder that requires immediate open access (e.g. according to Plan S principles <https://www.springernature.com/gp/open-research/plan-s-compliance>) then you should select the gold OA route, and we will direct you to the compliant route where possible. For authors selecting the subscription publication route, the journal’s standard licensing terms will need to be accepted, including self-archiving policies <https://www.springernature.com/gp/open-research/policies/journal-policies>. Those licensing terms will supersede any other terms that the author or any third party may assert apply to any version of the manuscript.
An online order form for reprints of your paper is available at <https://www.nature.com/reprints/author-reprints.html>https://www.nature.com/reprints/author-reprints.html <https://www.nature.com/reprints/author-reprints.html%3C/a%3E.>. All co-authors, authors' institutions and authors' funding agencies can order reprints using the form appropriate to their geographical region.
We welcome the submission of potential cover material (including a short caption of around 40 words) related to your manuscript; suggestions should be sent as electronic image files (the image should be 300 dpi at 210 x 297 mm in either TIFF or JPEG format).
You can now use a single sign-on for all your accounts, view the status of all your manuscript submissions and reviews, access usage statistics for your published articles and download a record of your refereeing activity for the Nature journals.
To assist our authors in disseminating their research to the broader community, our SharedIt initiative provides you with a unique shareable link that will allow anyone (with or without a subscription) to read the published article. Recipients of the link with a subscription will also be able to download and print the PDF.
In approximately 10 business days you will receive an email with a link to choose the appropriate publishing options for your paper and our Author Services team will be in touch regarding any additional information that may be required.
If you have any questions about our publishing options, costs, Open Access requirements, or our legal forms, please contact ASJournals@springernature.com
As soon as your article is published, you will receive an automated email with your shareable link.
Lastly, I would like to personally thank you for choosing Nature Photonics as the journal in which to disseminate your exciting research. It has been a pleasure working with you. We would welcome submissions reporting important findings from you in the future.
With kind regards,
Dr Giampaolo Pitruzzello Senior Editor Nature Photonics
** Visit the Springer Nature Editorial and Publishing website at www.springernature.com/editorial-and-publishing-jobs <http://editorial-jobs.springernature.com/?utm_source=ejP_NPhot_email&utm_med...> for more information about our career opportunities. If you have any questions please click here <mailto:editorial.publishing.jobs@springernature.com>.**
This email has been sent through the Springer Nature Tracking System NY-610A-NPG&MTS
Confidentiality Statement:
This e-mail is confidential and subject to copyright. Any unauthorised use or disclosure of its contents is prohibited. If you have received this email in error please notify our Manuscript Tracking System Helpdesk team at <http://platformsupport.nature.com/>http://platformsupport.nature.com <http://platformsupport.nature.com/> .
Details of the confidentiality and pre-publicity policy may be found here <http://www.nature.com/authors/policies/confidentiality.html>http://www.nature.com/authors/policies/confidentiality.html
Privacy Policy <http://www.nature.com/info/privacy.html> | Update Profile <https://mts-nphot.nature.com/>
🥳 Wow, congratulations! Thanks, I am in :) 17.4 or week after Easter on 23. , 24., 25. April would be possible for me, for example Am 2025-04-16 09:28, schrieb Pierre Bouvet:
I think the acceptance of the paper deserves a lab bar! When are you all available? Drinks on me :)
Best,
Pierre
_Pierre Bouvet, PhD_ _Post-doctoral Fellow_ _Medical University Vienna_ _Department of Anatomy and Cell Biology_ _Wahringer Straße 13, 1090 Wien, __Austria_
Begin forwarded message: From: giampaolo.pitruzzello@nature.com
Subject: [EXTERN] Final Decision made for NPHOT-2024-04-00624B
Date: 16. April 2025 at 00:52:09 GMT+2
To: pierre.bouvet@meduniwien.ac.at
Reply-To: giampaolo.pitruzzello@nature.com
Dear Dr Bouvet,
Please find below a copy of the decision letter for your manuscript "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials" [NPHOT-2024-04-00624B], which has just been accepted for publication in Nature Photonics.
You can now use a single sign-on for all your accounts, view the status of all your manuscript submissions and reviews, access usage statistics for your published articles and download a record of your refereeing activity for the Nature journals.
To assist our authors in disseminating their research to the broader community, our SharedIt initiative provides all co-authors with the ability to generate a unique shareable link that will allow anyone (with or without a subscription) to read the published article. Recipients of the link with a subscription will also be able to download and print the PDF.
As soon as your article is published, you can generate your shareable link by entering the DOI of your article here: http://authors.springernature.com/share. Corresponding authors will also receive an automated email with the shareable link.
Sincerely,
Dr Giampaolo Pitruzzello Senior Editor Nature Photonics
------------------------------------------------------------------------ Subject: Acceptance note for Nature Photonics manuscript NPHOT-2024-04-00624B
15th April 2025
Dear Kareem,
All your hard work has paid off and I am delighted to inform you that your manuscript, "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials", has now been formally accepted for publication in Nature Photonics. Congratulations! It's been a long journey and I am so glad to see this piece now finalised. I do think it will be a valuable resource for the Brillouin community.
Before your manuscript is typeset, we will edit the text to ensure that your findings are clear to our wide readership and that the paper conforms with Nature Photonics style. We look particularly carefully at the titles of all papers to ensure that they are concise and clear.
Once your manuscript is typeset and you have completed the appropriate grant of rights, you will receive a link to your electronic proof via email with a request to make any corrections within 48 hours. If, when you receive your proof, you cannot meet this deadline, please inform us at rjsproduction@springernature.com immediately.
You may wish to make your media relations office aware of your accepted publication, in case they consider it appropriate to organize some internal or external publicity. Once your paper has been scheduled you will receive an email confirming the publication details. This is normally 3-4 working days in advance of publication. If you need additional notice of the date and time of publication, please let the production team know when you receive the proof of your article to ensure there is sufficient time to coordinate. Further information on our embargo policies can be found here: https://www.nature.com/authors/policies/embargo.html
Acceptance of your manuscript is conditional upon all authors' agreement with our publication policies (see http://www.nature.com/nphoton/authors/index.html#publishing-policies). In particular, your manuscript must not be published elsewhere and there must be no announcement of the work to any media outlet until the publication date (the day on which it is uploaded onto our website).
Authors may need to take specific actions to achieve compliance [1] with funder and institutional open access mandates. If your research is supported by a funder that requires immediate open access (e.g. according to Plan S principles [2]) then you should select the gold OA route, and we will direct you to the compliant route where possible. For authors selecting the subscription publication route, the journal's standard licensing terms will need to be accepted, including self-archiving policies [3]. Those licensing terms will supersede any other terms that the author or any third party may assert apply to any version of the manuscript.
An online order form for reprints of your paper is available at https://www.nature.com/reprints/author-reprints.html [4]. All co-authors, authors' institutions and authors' funding agencies can order reprints using the form appropriate to their geographical region.
We welcome the submission of potential cover material (including a short caption of around 40 words) related to your manuscript; suggestions should be sent as electronic image files (the image should be 300 dpi at 210 x 297 mm in either TIFF or JPEG format).
You can now use a single sign-on for all your accounts, view the status of all your manuscript submissions and reviews, access usage statistics for your published articles and download a record of your refereeing activity for the Nature journals.
To assist our authors in disseminating their research to the broader community, our SharedIt initiative provides you with a unique shareable link that will allow anyone (with or without a subscription) to read the published article. Recipients of the link with a subscription will also be able to download and print the PDF.
In approximately 10 business days you will receive an email with a link to choose the appropriate publishing options for your paper and our Author Services team will be in touch regarding any additional information that may be required.
If you have any questions about our publishing options, costs, Open Access requirements, or our legal forms, please contact ASJournals@springernature.com
As soon as your article is published, you will receive an automated email with your shareable link.
Lastly, I would like to personally thank you for choosing Nature Photonics as the journal in which to disseminate your exciting research. It has been a pleasure working with you. We would welcome submissions reporting important findings from you in the future.
With kind regards,
Dr Giampaolo Pitruzzello Senior Editor Nature Photonics
** Visit the Springer Nature Editorial and Publishing website at www.springernature.com/editorial-and-publishing-jobs [5] for more information about our career opportunities. If you have any questions please click here.**
This email has been sent through the Springer Nature Tracking System NY-610A-NPG&MTS
Confidentiality Statement:
This e-mail is confidential and subject to copyright. Any unauthorised use or disclosure of its contents is prohibited. If you have received this email in error please notify our Manuscript Tracking System Helpdesk team at http://platformsupport.nature.com [6] .
_Details of the confidentiality and pre-publicity policy may be found here http://www.nature.com/authors/policies/confidentiality.html _
Privacy Policy [7] | Update Profile [8]
_______________________________________________ Lab mailing list -- muw@biobrillouin.org To unsubscribe send an email to muw-leave@biobrillouin.org
Links: ------ [1] https://www.springernature.com/gp/open-research/funding/policy-compliance-fa... [2] https://www.springernature.com/gp/open-research/plan-s-compliance [3] https://www.springernature.com/gp/open-research/policies/journal-policies [4] https://www.nature.com/reprints/author-reprints.html%3C/a%3E. [5] http://editorial-jobs.springernature.com/?utm_source=ejP_NPhot_email&utm_medium=ejP_NPhot_email&utm_campaign=ejp_NPhot [6] http://platformsupport.nature.com/ [7] http://www.nature.com/info/privacy.html [8] https://mts-nphot.nature.com/
Great, how about tomorrow (17/4)? No – drinks are on the lab 😊 From: Jennifer Illibauer <jennifer.illibauer@meduniwien.ac.at> Date: Wednesday, 16. April 2025 at 12:13 To: Pierre Bouvet <pierre.bouvet@meduniwien.ac.at> Cc: "muw@biobrillouin.org" <muw@biobrillouin.org> Subject: [Lab] Re: Fwd: [EXTERN] Final Decision made for NPHOT-2024-04-00624B 🥳 Wow, congratulations! Thanks, I am in :) 17.4 or week after Easter on 23. , 24., 25. April would be possible for me, for example Am 2025-04-16 09:28, schrieb Pierre Bouvet: I think the acceptance of the paper deserves a lab bar! When are you all available? Drinks on me :) Best, Pierre Pierre Bouvet, PhD Post-doctoral Fellow Medical University Vienna Department of Anatomy and Cell Biology Wahringer Straße 13, 1090 Wien, Austria Begin forwarded message: From: giampaolo.pitruzzello@nature.com Subject: [EXTERN] Final Decision made for NPHOT-2024-04-00624B Date: 16. April 2025 at 00:52:09 GMT+2 To: pierre.bouvet@meduniwien.ac.at Reply-To: giampaolo.pitruzzello@nature.com Dear Dr Bouvet, Please find below a copy of the decision letter for your manuscript "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials" [NPHOT-2024-04-00624B], which has just been accepted for publication in Nature Photonics. You can now use a single sign-on for all your accounts, view the status of all your manuscript submissions and reviews, access usage statistics for your published articles and download a record of your refereeing activity for the Nature journals. To assist our authors in disseminating their research to the broader community, our SharedIt initiative provides all co-authors with the ability to generate a unique shareable link that will allow anyone (with or without a subscription) to read the published article. Recipients of the link with a subscription will also be able to download and print the PDF. As soon as your article is published, you can generate your shareable link by entering the DOI of your article here: http://authors.springernature.com/share. Corresponding authors will also receive an automated email with the shareable link. Sincerely, Dr Giampaolo Pitruzzello Senior Editor Nature Photonics ------------------------------------------------------------------------ Subject: Acceptance note for Nature Photonics manuscript NPHOT-2024-04-00624B 15th April 2025 Dear Kareem, All your hard work has paid off and I am delighted to inform you that your manuscript, "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials", has now been formally accepted for publication in Nature Photonics. Congratulations! It's been a long journey and I am so glad to see this piece now finalised. I do think it will be a valuable resource for the Brillouin community. Before your manuscript is typeset, we will edit the text to ensure that your findings are clear to our wide readership and that the paper conforms with Nature Photonics style. We look particularly carefully at the titles of all papers to ensure that they are concise and clear. Once your manuscript is typeset and you have completed the appropriate grant of rights, you will receive a link to your electronic proof via email with a request to make any corrections within 48 hours. If, when you receive your proof, you cannot meet this deadline, please inform us at rjsproduction@springernature.com immediately. You may wish to make your media relations office aware of your accepted publication, in case they consider it appropriate to organize some internal or external publicity. Once your paper has been scheduled you will receive an email confirming the publication details. This is normally 3-4 working days in advance of publication. If you need additional notice of the date and time of publication, please let the production team know when you receive the proof of your article to ensure there is sufficient time to coordinate. Further information on our embargo policies can be found here: https://www.nature.com/authors/policies/embargo.html Acceptance of your manuscript is conditional upon all authors' agreement with our publication policies (see http://www.nature.com/nphoton/authors/index.html#publishing-policies). In particular, your manuscript must not be published elsewhere and there must be no announcement of the work to any media outlet until the publication date (the day on which it is uploaded onto our website). Authors may need to take specific actions to achieve compliance with funder and institutional open access mandates. If your research is supported by a funder that requires immediate open access (e.g. according to Plan S principles) then you should select the gold OA route, and we will direct you to the compliant route where possible. For authors selecting the subscription publication route, the journal's standard licensing terms will need to be accepted, including self-archiving policies. Those licensing terms will supersede any other terms that the author or any third party may assert apply to any version of the manuscript. An online order form for reprints of your paper is available at https://www.nature.com/reprints/author-reprints.html. All co-authors, authors' institutions and authors' funding agencies can order reprints using the form appropriate to their geographical region. We welcome the submission of potential cover material (including a short caption of around 40 words) related to your manuscript; suggestions should be sent as electronic image files (the image should be 300 dpi at 210 x 297 mm in either TIFF or JPEG format). You can now use a single sign-on for all your accounts, view the status of all your manuscript submissions and reviews, access usage statistics for your published articles and download a record of your refereeing activity for the Nature journals. To assist our authors in disseminating their research to the broader community, our SharedIt initiative provides you with a unique shareable link that will allow anyone (with or without a subscription) to read the published article. Recipients of the link with a subscription will also be able to download and print the PDF. In approximately 10 business days you will receive an email with a link to choose the appropriate publishing options for your paper and our Author Services team will be in touch regarding any additional information that may be required. If you have any questions about our publishing options, costs, Open Access requirements, or our legal forms, please contact ASJournals@springernature.com As soon as your article is published, you will receive an automated email with your shareable link. Lastly, I would like to personally thank you for choosing Nature Photonics as the journal in which to disseminate your exciting research. It has been a pleasure working with you. We would welcome submissions reporting important findings from you in the future. With kind regards, Dr Giampaolo Pitruzzello Senior Editor Nature Photonics ** Visit the Springer Nature Editorial and Publishing website at www.springernature.com/editorial-and-publishing-jobs for more information about our career opportunities. If you have any questions please click here.** This email has been sent through the Springer Nature Tracking System NY-610A-NPG&MTS Confidentiality Statement: This e-mail is confidential and subject to copyright. Any unauthorised use or disclosure of its contents is prohibited. If you have received this email in error please notify our Manuscript Tracking System Helpdesk team at http://platformsupport.nature.com . Details of the confidentiality and pre-publicity policy may be found here http://www.nature.com/authors/policies/confidentiality.html Privacy Policy | Update Profile _______________________________________________ Lab mailing list -- muw@biobrillouin.org To unsubscribe send an email to muw-leave@biobrillouin.org
OK for me :) Pierre Bouvet, PhD Post-doctoral Fellow Medical University Vienna Department of Anatomy and Cell Biology Wahringer Straße 13, 1090 Wien, Austria
On 16/4/25, at 12:19, Kareem Elsayad <kareem.elsayad@meduniwien.ac.at> wrote:
Great, how about tomorrow (17/4)? No – drinks are on the lab 😊
From: Jennifer Illibauer <jennifer.illibauer@meduniwien.ac.at <mailto:jennifer.illibauer@meduniwien.ac.at>> Date: Wednesday, 16. April 2025 at 12:13 To: Pierre Bouvet <pierre.bouvet@meduniwien.ac.at <mailto:pierre.bouvet@meduniwien.ac.at>> Cc: "muw@biobrillouin.org <mailto:muw@biobrillouin.org>" <muw@biobrillouin.org <mailto:muw@biobrillouin.org>> Subject: [Lab] Re: Fwd: [EXTERN] Final Decision made for NPHOT-2024-04-00624B
🥳 Wow, congratulations! Thanks, I am in :) 17.4 or week after Easter on 23. , 24., 25. April would be possible for me, for example
Am 2025-04-16 09:28, schrieb Pierre Bouvet:
I think the acceptance of the paper deserves a lab bar! When are you all available? Drinks on me :)
Best,
Pierre
Pierre Bouvet, PhD Post-doctoral Fellow Medical University Vienna Department of Anatomy and Cell Biology Wahringer Straße 13, 1090 Wien, Austria
Begin forwarded message:
From: giampaolo.pitruzzello@nature.com <mailto:giampaolo.pitruzzello@nature.com> Subject: [EXTERN] Final Decision made for NPHOT-2024-04-00624B Date: 16. April 2025 at 00:52:09 GMT+2 To: pierre.bouvet@meduniwien.ac.at <mailto:pierre.bouvet@meduniwien.ac.at> Reply-To: giampaolo.pitruzzello@nature.com <mailto:giampaolo.pitruzzello@nature.com>
Dear Dr Bouvet,
Please find below a copy of the decision letter for your manuscript "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials" [NPHOT-2024-04-00624B], which has just been accepted for publication in Nature Photonics.
You can now use a single sign-on for all your accounts, view the status of all your manuscript submissions and reviews, access usage statistics for your published articles and download a record of your refereeing activity for the Nature journals.
To assist our authors in disseminating their research to the broader community, our SharedIt initiative provides all co-authors with the ability to generate a unique shareable link that will allow anyone (with or without a subscription) to read the published article. Recipients of the link with a subscription will also be able to download and print the PDF.
As soon as your article is published, you can generate your shareable link by entering the DOI of your article here: http://authors.springernature.com/share. Corresponding authors will also receive an automated email with the shareable link.
Sincerely,
Dr Giampaolo Pitruzzello Senior Editor Nature Photonics
------------------------------------------------------------------------ Subject: Acceptance note for Nature Photonics manuscript NPHOT-2024-04-00624B
15th April 2025
Dear Kareem,
All your hard work has paid off and I am delighted to inform you that your manuscript, "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials", has now been formally accepted for publication in Nature Photonics. Congratulations! It's been a long journey and I am so glad to see this piece now finalised. I do think it will be a valuable resource for the Brillouin community.
Before your manuscript is typeset, we will edit the text to ensure that your findings are clear to our wide readership and that the paper conforms with Nature Photonics style. We look particularly carefully at the titles of all papers to ensure that they are concise and clear.
Once your manuscript is typeset and you have completed the appropriate grant of rights, you will receive a link to your electronic proof via email with a request to make any corrections within 48 hours. If, when you receive your proof, you cannot meet this deadline, please inform us at rjsproduction@springernature.com <mailto:rjsproduction@springernature.com> immediately.
You may wish to make your media relations office aware of your accepted publication, in case they consider it appropriate to organize some internal or external publicity. Once your paper has been scheduled you will receive an email confirming the publication details. This is normally 3-4 working days in advance of publication. If you need additional notice of the date and time of publication, please let the production team know when you receive the proof of your article to ensure there is sufficient time to coordinate. Further information on our embargo policies can be found here: https://www.nature.com/authors/policies/embargo.html
Acceptance of your manuscript is conditional upon all authors' agreement with our publication policies (see http://www.nature.com/nphoton/authors/index.html#publishing-policies). In particular, your manuscript must not be published elsewhere and there must be no announcement of the work to any media outlet until the publication date (the day on which it is uploaded onto our website).
Authors may need to take specific actions to achieve compliance <https://www.springernature.com/gp/open-research/funding/policy-compliance-fa...> with funder and institutional open access mandates. If your research is supported by a funder that requires immediate open access (e.g. according to Plan S principles <https://www.springernature.com/gp/open-research/plan-s-compliance>) then you should select the gold OA route, and we will direct you to the compliant route where possible. For authors selecting the subscription publication route, the journal's standard licensing terms will need to be accepted, including self-archiving policies <https://www.springernature.com/gp/open-research/policies/journal-policies>. Those licensing terms will supersede any other terms that the author or any third party may assert apply to any version of the manuscript.
An online order form for reprints of your paper is available at https://www.nature.com/reprints/author-reprints.html <https://www.nature.com/reprints/author-reprints.html%3C/a%3E.>. All co-authors, authors' institutions and authors' funding agencies can order reprints using the form appropriate to their geographical region.
We welcome the submission of potential cover material (including a short caption of around 40 words) related to your manuscript; suggestions should be sent as electronic image files (the image should be 300 dpi at 210 x 297 mm in either TIFF or JPEG format).
You can now use a single sign-on for all your accounts, view the status of all your manuscript submissions and reviews, access usage statistics for your published articles and download a record of your refereeing activity for the Nature journals.
To assist our authors in disseminating their research to the broader community, our SharedIt initiative provides you with a unique shareable link that will allow anyone (with or without a subscription) to read the published article. Recipients of the link with a subscription will also be able to download and print the PDF.
In approximately 10 business days you will receive an email with a link to choose the appropriate publishing options for your paper and our Author Services team will be in touch regarding any additional information that may be required.
If you have any questions about our publishing options, costs, Open Access requirements, or our legal forms, please contact ASJournals@springernature.com <mailto:ASJournals@springernature.com>
As soon as your article is published, you will receive an automated email with your shareable link.
Lastly, I would like to personally thank you for choosing Nature Photonics as the journal in which to disseminate your exciting research. It has been a pleasure working with you. We would welcome submissions reporting important findings from you in the future.
With kind regards,
Dr Giampaolo Pitruzzello Senior Editor Nature Photonics
** Visit the Springer Nature Editorial and Publishing website at www.springernature.com/editorial-and-publishing-jobs <http://editorial-jobs.springernature.com/?utm_source=ejP_NPhot_email&utm_med...> for more information about our career opportunities. If you have any questions please click here <mailto:editorial.publishing.jobs@springernature.com>.**
This email has been sent through the Springer Nature Tracking System NY-610A-NPG&MTS
Confidentiality Statement:
This e-mail is confidential and subject to copyright. Any unauthorised use or disclosure of its contents is prohibited. If you have received this email in error please notify our Manuscript Tracking System Helpdesk team at http://platformsupport.nature.com <http://platformsupport.nature.com/> . Details of the confidentiality and pre-publicity policy may be found here http://www.nature.com/authors/policies/confidentiality.html Privacy Policy <http://www.nature.com/info/privacy.html> | Update Profile <https://mts-nphot.nature.com/>
_______________________________________________ Lab mailing list -- muw@biobrillouin.org <mailto:muw@biobrillouin.org> To unsubscribe send an email to muw-leave@biobrillouin.org <mailto:muw-leave@biobrillouin.org>
👍🏼 for me Am 2025-04-16 12:19, schrieb Kareem Elsayad:
Great, how about tomorrow (17/4)?
No - drinks are on the lab 😊
From: Jennifer Illibauer <jennifer.illibauer@meduniwien.ac.at> Date: Wednesday, 16. April 2025 at 12:13 To: Pierre Bouvet <pierre.bouvet@meduniwien.ac.at> Cc: "muw@biobrillouin.org" <muw@biobrillouin.org> Subject: [Lab] Re: Fwd: [EXTERN] Final Decision made for NPHOT-2024-04-00624B
🥳 Wow, congratulations!
Thanks, I am in :)
17.4 or week after Easter on 23. , 24., 25. April would be possible for me, for example
Am 2025-04-16 09:28, schrieb Pierre Bouvet:
I think the acceptance of the paper deserves a lab bar! When are you all available? Drinks on me :)
Best,
Pierre
_Pierre Bouvet, PhD_
_Post-doctoral Fellow_
_Medical University Vienna_
_Department of Anatomy and Cell Biology_
_Wahringer Straße 13, 1090 Wien, Austria_
Begin forwarded message:
From: giampaolo.pitruzzello@nature.com
Subject: [EXTERN] Final Decision made for NPHOT-2024-04-00624B
Date: 16. April 2025 at 00:52:09 GMT+2
To: pierre.bouvet@meduniwien.ac.at
Reply-To: giampaolo.pitruzzello@nature.com
Dear Dr Bouvet,
Please find below a copy of the decision letter for your manuscript "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials" [NPHOT-2024-04-00624B], which has just been accepted for publication in Nature Photonics.
You can now use a single sign-on for all your accounts, view the status of all your manuscript submissions and reviews, access usage statistics for your published articles and download a record of your refereeing activity for the Nature journals.
To assist our authors in disseminating their research to the broader community, our SharedIt initiative provides all co-authors with the ability to generate a unique shareable link that will allow anyone (with or without a subscription) to read the published article. Recipients of the link with a subscription will also be able to download and print the PDF.
As soon as your article is published, you can generate your shareable link by entering the DOI of your article here: http://authors.springernature.com/share. Corresponding authors will also receive an automated email with the shareable link.
Sincerely,
Dr Giampaolo Pitruzzello Senior Editor Nature Photonics
------------------------------------------------------------------------ Subject: Acceptance note for Nature Photonics manuscript NPHOT-2024-04-00624B
15th April 2025
Dear Kareem,
All your hard work has paid off and I am delighted to inform you that your manuscript, "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials", has now been formally accepted for publication in Nature Photonics. Congratulations! It's been a long journey and I am so glad to see this piece now finalised. I do think it will be a valuable resource for the Brillouin community.
Before your manuscript is typeset, we will edit the text to ensure that your findings are clear to our wide readership and that the paper conforms with Nature Photonics style. We look particularly carefully at the titles of all papers to ensure that they are concise and clear.
Once your manuscript is typeset and you have completed the appropriate grant of rights, you will receive a link to your electronic proof via email with a request to make any corrections within 48 hours. If, when you receive your proof, you cannot meet this deadline, please inform us at rjsproduction@springernature.com immediately.
You may wish to make your media relations office aware of your accepted publication, in case they consider it appropriate to organize some internal or external publicity. Once your paper has been scheduled you will receive an email confirming the publication details. This is normally 3-4 working days in advance of publication. If you need additional notice of the date and time of publication, please let the production team know when you receive the proof of your article to ensure there is sufficient time to coordinate. Further information on our embargo policies can be found here: https://www.nature.com/authors/policies/embargo.html
Acceptance of your manuscript is conditional upon all authors' agreement with our publication policies (see http://www.nature.com/nphoton/authors/index.html#publishing-policies). In particular, your manuscript must not be published elsewhere and there must be no announcement of the work to any media outlet until the publication date (the day on which it is uploaded onto our website).
Authors may need to take specific actions to achieve compliance [1] with funder and institutional open access mandates. If your research is supported by a funder that requires immediate open access (e.g. according to Plan S principles [2]) then you should select the gold OA route, and we will direct you to the compliant route where possible. For authors selecting the subscription publication route, the journal's standard licensing terms will need to be accepted, including self-archiving policies [3]. Those licensing terms will supersede any other terms that the author or any third party may assert apply to any version of the manuscript.
An online order form for reprints of your paper is available at https://www.nature.com/reprints/author-reprints.html [4]. All co-authors, authors' institutions and authors' funding agencies can order reprints using the form appropriate to their geographical region.
We welcome the submission of potential cover material (including a short caption of around 40 words) related to your manuscript; suggestions should be sent as electronic image files (the image should be 300 dpi at 210 x 297 mm in either TIFF or JPEG format).
You can now use a single sign-on for all your accounts, view the status of all your manuscript submissions and reviews, access usage statistics for your published articles and download a record of your refereeing activity for the Nature journals.
To assist our authors in disseminating their research to the broader community, our SharedIt initiative provides you with a unique shareable link that will allow anyone (with or without a subscription) to read the published article. Recipients of the link with a subscription will also be able to download and print the PDF.
In approximately 10 business days you will receive an email with a link to choose the appropriate publishing options for your paper and our Author Services team will be in touch regarding any additional information that may be required.
If you have any questions about our publishing options, costs, Open Access requirements, or our legal forms, please contact ASJournals@springernature.com
As soon as your article is published, you will receive an automated email with your shareable link.
Lastly, I would like to personally thank you for choosing Nature Photonics as the journal in which to disseminate your exciting research. It has been a pleasure working with you. We would welcome submissions reporting important findings from you in the future.
With kind regards,
Dr Giampaolo Pitruzzello Senior Editor Nature Photonics
** Visit the Springer Nature Editorial and Publishing website at www.springernature.com/editorial-and-publishing-jobs [5] for more information about our career opportunities. If you have any questions please click here.**
This email has been sent through the Springer Nature Tracking System NY-610A-NPG&MTS
_Confidentiality Statement:_
_This e-mail is confidential and subject to copyright. Any unauthorised use or disclosure of its contents is prohibited. If you have received this email in error please notify our Manuscript Tracking System Helpdesk team at http://platformsupport.nature.com [6] . _
_Details of the confidentiality and pre-publicity policy may be found here http://www.nature.com/authors/policies/confidentiality.html _
Privacy Policy [7] | Update Profile [8]
_______________________________________________ Lab mailing list -- muw@biobrillouin.org To unsubscribe send an email to muw-leave@biobrillouin.org
Links: ------ [1] https://www.springernature.com/gp/open-research/funding/policy-compliance-fa... [2] https://www.springernature.com/gp/open-research/plan-s-compliance [3] https://www.springernature.com/gp/open-research/policies/journal-policies [4] https://www.nature.com/reprints/author-reprints.html%3C/a%3E. [5] http://editorial-jobs.springernature.com/?utm_source=ejP_NPhot_email&utm_medium=ejP_NPhot_email&utm_campaign=ejp_NPhot [6] http://platformsupport.nature.com/ [7] http://www.nature.com/info/privacy.html [8] https://mts-nphot.nature.com/
Sincerest congrats to Kareem and the whole lab!!! Enjoy the drinks! I am still in Lyon at the AERC conference, but also on holidays next week. Please accept my apologize that I cannot join you to celebrate this great success! Thanks a lot and Happy Easter to everybody! Ursula Am 2025-04-16 13:25, schrieb Jennifer Illibauer:
👍🏼 for me
Am 2025-04-16 12:19, schrieb Kareem Elsayad:
Great, how about tomorrow (17/4)?
No - drinks are on the lab 😊
From: Jennifer Illibauer <jennifer.illibauer@meduniwien.ac.at> Date: Wednesday, 16. April 2025 at 12:13 To: Pierre Bouvet <pierre.bouvet@meduniwien.ac.at> Cc: "muw@biobrillouin.org" <muw@biobrillouin.org> Subject: [Lab] Re: Fwd: [EXTERN] Final Decision made for NPHOT-2024-04-00624B
🥳 Wow, congratulations!
Thanks, I am in :)
17.4 or week after Easter on 23. , 24., 25. April would be possible for me, for example
Am 2025-04-16 09:28, schrieb Pierre Bouvet:
I think the acceptance of the paper deserves a lab bar! When are you all available? Drinks on me :)
Best,
Pierre
_Pierre Bouvet, PhD_
_Post-doctoral Fellow_
_Medical University Vienna_
_Department of Anatomy and Cell Biology_
_Wahringer Straße 13, 1090 Wien, Austria_
Begin forwarded message:
From: giampaolo.pitruzzello@nature.com
Subject: [EXTERN] Final Decision made for NPHOT-2024-04-00624B
Date: 16. April 2025 at 00:52:09 GMT+2
To: pierre.bouvet@meduniwien.ac.at
Reply-To: giampaolo.pitruzzello@nature.com
Dear Dr Bouvet,
Please find below a copy of the decision letter for your manuscript "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials" [NPHOT-2024-04-00624B], which has just been accepted for publication in Nature Photonics.
You can now use a single sign-on for all your accounts, view the status of all your manuscript submissions and reviews, access usage statistics for your published articles and download a record of your refereeing activity for the Nature journals.
To assist our authors in disseminating their research to the broader community, our SharedIt initiative provides all co-authors with the ability to generate a unique shareable link that will allow anyone (with or without a subscription) to read the published article. Recipients of the link with a subscription will also be able to download and print the PDF.
As soon as your article is published, you can generate your shareable link by entering the DOI of your article here: http://authors.springernature.com/share. Corresponding authors will also receive an automated email with the shareable link.
Sincerely,
Dr Giampaolo Pitruzzello Senior Editor Nature Photonics
------------------------------------------------------------------------ Subject: Acceptance note for Nature Photonics manuscript NPHOT-2024-04-00624B
15th April 2025
Dear Kareem,
All your hard work has paid off and I am delighted to inform you that your manuscript, "Consensus Statement on Brillouin Light Scattering Microscopy of Biological Materials", has now been formally accepted for publication in Nature Photonics. Congratulations! It's been a long journey and I am so glad to see this piece now finalised. I do think it will be a valuable resource for the Brillouin community.
Before your manuscript is typeset, we will edit the text to ensure that your findings are clear to our wide readership and that the paper conforms with Nature Photonics style. We look particularly carefully at the titles of all papers to ensure that they are concise and clear.
Once your manuscript is typeset and you have completed the appropriate grant of rights, you will receive a link to your electronic proof via email with a request to make any corrections within 48 hours. If, when you receive your proof, you cannot meet this deadline, please inform us at rjsproduction@springernature.com immediately.
You may wish to make your media relations office aware of your accepted publication, in case they consider it appropriate to organize some internal or external publicity. Once your paper has been scheduled you will receive an email confirming the publication details. This is normally 3-4 working days in advance of publication. If you need additional notice of the date and time of publication, please let the production team know when you receive the proof of your article to ensure there is sufficient time to coordinate. Further information on our embargo policies can be found here: https://www.nature.com/authors/policies/embargo.html
Acceptance of your manuscript is conditional upon all authors' agreement with our publication policies (see http://www.nature.com/nphoton/authors/index.html#publishing-policies). In particular, your manuscript must not be published elsewhere and there must be no announcement of the work to any media outlet until the publication date (the day on which it is uploaded onto our website).
Authors may need to take specific actions to achieve compliance [1] with funder and institutional open access mandates. If your research is supported by a funder that requires immediate open access (e.g. according to Plan S principles [2]) then you should select the gold OA route, and we will direct you to the compliant route where possible. For authors selecting the subscription publication route, the journal's standard licensing terms will need to be accepted, including self-archiving policies [3]. Those licensing terms will supersede any other terms that the author or any third party may assert apply to any version of the manuscript.
An online order form for reprints of your paper is available at https://www.nature.com/reprints/author-reprints.html [4]. All co-authors, authors' institutions and authors' funding agencies can order reprints using the form appropriate to their geographical region.
We welcome the submission of potential cover material (including a short caption of around 40 words) related to your manuscript; suggestions should be sent as electronic image files (the image should be 300 dpi at 210 x 297 mm in either TIFF or JPEG format).
You can now use a single sign-on for all your accounts, view the status of all your manuscript submissions and reviews, access usage statistics for your published articles and download a record of your refereeing activity for the Nature journals.
To assist our authors in disseminating their research to the broader community, our SharedIt initiative provides you with a unique shareable link that will allow anyone (with or without a subscription) to read the published article. Recipients of the link with a subscription will also be able to download and print the PDF.
In approximately 10 business days you will receive an email with a link to choose the appropriate publishing options for your paper and our Author Services team will be in touch regarding any additional information that may be required.
If you have any questions about our publishing options, costs, Open Access requirements, or our legal forms, please contact ASJournals@springernature.com
As soon as your article is published, you will receive an automated email with your shareable link.
Lastly, I would like to personally thank you for choosing Nature Photonics as the journal in which to disseminate your exciting research. It has been a pleasure working with you. We would welcome submissions reporting important findings from you in the future.
With kind regards,
Dr Giampaolo Pitruzzello Senior Editor Nature Photonics
** Visit the Springer Nature Editorial and Publishing website at www.springernature.com/editorial-and-publishing-jobs [5] for more information about our career opportunities. If you have any questions please click here.**
This email has been sent through the Springer Nature Tracking System NY-610A-NPG&MTS
_Confidentiality Statement:_
_This e-mail is confidential and subject to copyright. Any unauthorised use or disclosure of its contents is prohibited. If you have received this email in error please notify our Manuscript Tracking System Helpdesk team at http://platformsupport.nature.com [6] . _
_Details of the confidentiality and pre-publicity policy may be found here http://www.nature.com/authors/policies/confidentiality.html _
Privacy Policy [7] | Update Profile [8]
_______________________________________________ Lab mailing list -- muw@biobrillouin.org To unsubscribe send an email to muw-leave@biobrillouin.org
_______________________________________________ Lab mailing list -- muw@biobrillouin.org To unsubscribe send an email to muw-leave@biobrillouin.org -- Ursula Windberger, DVM, BSc associate professor Center for Anatomy and Cell Biology Medical University Vienna Währingerstrasse 13, 1090 Vienna ursula.windberger@meduniwien.ac.at president of the Austrian Society for Rheology www.rheology.at [9] www.rheo.at [10] Links: ------ [1] https://www.springernature.com/gp/open-research/funding/policy-compliance-fa... [2] https://www.springernature.com/gp/open-research/plan-s-compliance [3] https://www.springernature.com/gp/open-research/policies/journal-policies [4] https://www.nature.com/reprints/author-reprints.html%3C/a%3E. [5] http://editorial-jobs.springernature.com/?utm_source=ejP_NPhot_email&utm_medium=ejP_NPhot_email&utm_campaign=ejp_NPhot [6] http://platformsupport.nature.com/ [7] http://www.nature.com/info/privacy.html [8] https://mts-nphot.nature.com/ [9] http://www.rheology.at [10] http://www.rheo.at
participants (4)
-
Jennifer Illibauer -
Kareem Elsayad -
Pierre Bouvet -
Ursula Windberger